Labcorp Holdings Inc. (LON:0JSY)

Market Cap	16.48B
Revenue (ttm)	10.39B
Net Income (ttm)	595.88M
Shares Out	n/a
EPS (ttm)	7.06
PE Ratio	27.66
Forward PE	n/a
Dividend	2.25 (0.91%)
Ex-Dividend Date	Feb 27, 2025

Volume	70
Average Volume	245
Open	248.46
Previous Close	248.91
Day's Range	248.46 - 248.89
52-Week Range	195.90 - 248.38
Beta	1.05
RSI	58.33
Earnings Date	Feb 6, 2025

About Labcorp Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests tar...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1995
• Employees: 70,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0JSY

Financial Performance

In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.

Financial numbers in USD